Over the last 7 days, the Pharma industry has dropped 2.7%, driven by Orion Oyj declining 2.7%. However, the industry is down 30% over the past year. As for the next few years, earnings are expected to grow by 10% per annum.
Has the Finnish Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Tue, 23 Apr 2024 | €4.6b | €1.2b | €217.1m | 62.2x | 21.1x | 3.9x |
Thu, 21 Mar 2024 | €5.0b | €1.2b | €217.1m | 62.6x | 22.9x | 4.2x |
Sat, 17 Feb 2024 | €5.6b | €1.2b | €216.8m | 25.9x | 25.9x | 4.7x |
Mon, 15 Jan 2024 | €6.0b | €1.2b | €173.2m | 34.6x | 34.6x | 5.2x |
Wed, 13 Dec 2023 | €5.1b | €1.2b | €173.2m | 29.2x | 29.3x | 4.4x |
Fri, 10 Nov 2023 | €5.3b | €1.2b | €173.2m | 30.4x | 30.3x | 4.5x |
Sun, 08 Oct 2023 | €5.5b | €1.4b | €306.3m | 17.8x | 17.8x | 4x |
Tue, 05 Sep 2023 | €5.3b | €1.4b | €306.3m | 17.3x | 17.3x | 3.9x |
Thu, 03 Aug 2023 | €4.9b | €1.4b | €306.3m | 15.8x | 15.9x | 3.6x |
Sat, 01 Jul 2023 | €5.4b | €1.3b | €336.0m | 15.9x | 16x | 4x |
Mon, 29 May 2023 | €5.7b | €1.3b | €336.0m | 17.1x | 17x | 4.2x |
Wed, 26 Apr 2023 | €6.6b | €1.3b | €349.5m | 18.9x | 18.8x | 4.9x |
Fri, 24 Mar 2023 | €5.9b | €1.3b | €339.0m | 16.7x | 17.3x | 4.4x |
Sun, 19 Feb 2023 | €6.4b | €1.3b | €339.0m | 18.2x | 18.9x | 4.8x |
Tue, 17 Jan 2023 | €7.1b | €1.3b | €340.2m | 20.1x | 20.9x | 5.4x |
Thu, 15 Dec 2022 | €7.1b | €1.3b | €340.2m | 20.2x | 20.8x | 5.4x |
Sat, 12 Nov 2022 | €6.5b | €1.3b | €350.7m | 18.7x | 18.7x | 4.9x |
Mon, 10 Oct 2022 | €6.1b | €1.1b | €201.7m | 30.4x | 30.4x | 5.7x |
Wed, 07 Sep 2022 | €6.3b | €1.1b | €201.7m | 31.2x | 31.2x | 5.9x |
Fri, 05 Aug 2022 | €6.6b | €1.1b | €201.7m | 32.7x | 32.7x | 6.2x |
Sun, 03 Jul 2022 | €6.0b | €1.0b | €191.5m | 31.2x | 31.1x | 5.7x |
Tue, 31 May 2022 | €5.3b | €1.0b | €191.5m | 27.8x | 27.8x | 5.1x |
Thu, 28 Apr 2022 | €5.6b | €1.0b | €193.8m | 29x | 29x | 5.4x |
Sat, 26 Mar 2022 | €5.6b | €1.0b | €193.8m | 29.1x | 29x | 5.4x |
Mon, 21 Feb 2022 | €6.3b | €1.0b | €193.8m | 32.6x | 32.5x | 6.1x |
Wed, 19 Jan 2022 | €5.0b | €1.0b | €186.5m | 27x | 26.9x | 4.9x |
Fri, 17 Dec 2021 | €4.9b | €1.0b | €186.5m | 26.5x | 26.5x | 4.8x |
Sun, 14 Nov 2021 | €5.3b | €1.0b | €186.5m | 28.7x | 28.7x | 5.2x |
Tue, 12 Oct 2021 | €5.0b | €1.0b | €192.4m | 26.1x | 26.1x | 4.9x |
Thu, 09 Sep 2021 | €4.8b | €1.0b | €192.4m | 25.1x | 25.1x | 4.7x |
Sat, 07 Aug 2021 | €4.9b | €1.0b | €192.4m | 25.6x | 25.6x | 4.8x |
Fri, 30 Apr 2021 | €5.2b | €1.1b | €212.1m | 24.4x | 24.4x | 4.9x |
24.4x
How does Finnish Pharma compare with similar industries?
FI Market | -0.40% | |
Healthcare | -1.42% | |
Pharma | -1.44% | |
Pharma | -1.44% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ORNBV Orion Oyj | €33.00 | 0.4% +€16.9m | -28.4% | PE21.4x | |
HRTIS Herantis Pharma Oyj | €1.45 | 2.5% +€705.6k | -34.1% | PE104.5x |